Bifidobacterium lactis MAK16B42L and Reduced Visceral Fat

• Effect of Bifidobacterium animalis ssp. lactis GCL2505 on visceral fat accumulation in healthy Japanese adults: a randomized controlled trial

  • 2020-09-30
  • RCT · n = 137
  • Bioscience of Microbiota, Food and Health 35(4)
  • • Shota Takahashi
    • D. Anzawa
    • K. Takami
    • Akihiro Ishizuka
    • Takashi Mawatari
    • Kohei Kamikado
    • Haruhi Sugimura
    • Tomohiko Nishijima

  • PubMed: 27867803
  • DOI: 10.12938/bmfh.2016-002

  6 Insights on

  • Reduced Visceral Fat

  • High evidence
  • Rigorous Journal
  • Clinical

  Visceral fat area, but not subcutaneous fat area, was significantly reduced from baseline at 8 and 12 weeks in the GCL2505 group, compared with the placebo group.

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes